Solitary skull metastasis as initial manifestation of hepatocellular carcinoma by Shim, Yu Shik et al.
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
World Journal of Surgical Oncology
Open Access Case report
Solitary skull metastasis as initial manifestation of hepatocellular 
carcinoma
Yu Shik Shim1, Jung Yong Ahn1, Jun Hyung Cho*2 and Kyu Sung Lee1
Address: 1Department of Neurosurgery, Yonsei Brain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea and 
2Department of Neurosurgery, Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Republic of Korea
Email: Yu Shik Shim - shim60@yumc.yonsei.ac.kr; Jung Yong Ahn - jyahn@yumc.yonsei.ac.kr; Jun Hyung Cho* - junhc2028@gmail.com; 
Kyu Sung Lee - kyusung@yumc.yonsei.ac.kr
* Corresponding author    
Abstract
Background: A solitary skull metastasis from hepatocellular carcinoma (HCC) prior to diagnosis
of the primary tumor without liver dysfunction is a very rare event.
Case presentation: A 71-year-old male, without known liver disease, presented to our
institution with a palpable occipital scalp mass. On brain magnetic resonance imaging (MRI), a highly
enhanced and osteolytic skull tumor was observed. The histological diagnosis obtained from the
percutaneous needle biopsy was a cranial metastasis from HCC. The metastatic tumor was
removed via occipital craniectomy, and the two primary liver mass lesions were subsequently
treated by transarterial chemoembolization.
Conclusion: An isolated skull metastasis may be the sole initial presentation of HCC. Early
diagnosis is essential in order to treat the primary disease. A skull metastasis from HCC should be
considered in the differential diagnosis in patients with subcutaneous scalp mass and osteolytic
defects on X-ray.
Background
Hepatocellular carcinoma (HCC) is the fifth most com-
mon cancer in the world and is especially prevalent in
African and East Asia [1]. The higher incidence of HCC in
Asia is related to the increased prevalence of chronic viral
hepatitis B [2]. Late-stage HCC usually metastasizes to the
regional lymph nodes and lungs [3], but less commonly
to the skeleton. HCC usually metastasizes preferentially to
the vertebral column, pelvis, and ribs, but rarely to the
skull [4].
Although the incidence of bone metastases in HCC has
been described as very low in autopsy studies, an increas-
ing trend has been reported recently [4,5]. In the past,
because of its short survival of patients with HCC, their
clinical presentations were mostly concerned with the
manifestations of the primary cancer itself. However,
recent progress in the treatment of HCC has made it pos-
sible for the patient to survive longer, and as a result, dis-
tant metastasis from HCC, including bone metastasis, has
increased and attracted more attention than before [4].
In this report, we describe a patient without previously
known liver disease who presented with metastatic HCC
of the skull before the diagnosis of a primary cancer.
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Case presentation
A 71-year-old male presented with a scalp mass found
incidentally one month prior to presentation. He did not
have a history of a recent head trauma or of any significant
medical problems, including liver disease. However, he
had consumed seven alcoholic beverages (distilled liq-
uor) per week for the last 20 years. On admission, neuro-
logical and physical examination revealed no
neurological deficits or hepatomegaly. A soft and non-
movable mass about 3 × 4 cm over his occipital area was
noted. The mass was slowly growing and caused occasion-
ally mild regional tenderness. Laboratory tests demon-
strated normal liver function test, an alpha-fetoprotein
level of 2.5 ng/ml and a positive serologic test for hepatitis
C-virus (HCV) antibody. Identifiable risk factors for HCV
infection such as intravenous drug use, multiple sexual
partners, blood transfusion and receipt of blood-clotting
factors were not revealed in this patient. Polymerase chain
reaction to detect HCV RNA in the serum was not per-
formed. X-ray film of the skull showed an osteolytic skull
mass over the occipital midline area. On brain MRI, the
tumor was a homogenous, well-defined mass with
involvement of the inner and outer skull table. It revealed
iso-signal intensity on T1-weighted (Figure 1A) and T2-
weighted imaging (Figure 1B), with strong enhancement
by Gadolinium (Figure 1C). A percutaneous needle
biopsy showed pleomorphic tumor cells with eosi-
nophilic cytoplasms and prominent nucleoli arranged in
both a trabecular and solid pattern, findings that are con-
sistent with metastasis of HCC (Figure 2). A retrograde
diagnostic work-up for detecting the primary cancer was
performed. An abdominal CT scan revealed two separate,
low-density, 2-cm hepatic masses in segments II and IV of
the liver (Figure 3). An abdominal sonogram identified
nodular liver suggestive of cirrhosis. A total skeletal bone
scan and contrast-enhanced chest CT scan revealed no
other lesions.
Under general anesthesia, the tumor was radically
resected with surrounding normal bone via occipital
craniectomy. At the time of surgery, a grossly well-demar-
cated reddish-brown mass (reflecting its high vascularity)
penetrated both tables of the skull through the diploic
space (Figure 4). The underlying dura matter was intact
and did not show evidence of gross tumor-invasion. The
dural surface attached to the tumor was curetted and cau-
terized by the bipolar forceps. To treat the primary cancer,
transarterial chemoembolization with adriamycin (30
mg), lipiodol, and Gelfoam particles was performed after
selecting a feeding artery of the tumor on aortography.
The patient was still alive after 9 months of follow-up
without hepatic dysfunction due to the progression of pri-
mary cancer. He also did not show any evidence of the
recurrence of skull metastasis.
Discussion
The incidence of skeletal metastasis from HCC is esti-
mated to be 2%–16%, depending on the prevalence of the
primary disease in the population [4,6]. The most fre-
quent sites of osseous metastases from HCC are vertebrae,
the sternum, ribs, and long bones, although the incidence
in the skull is low at 0.5%–1.6% [1,7-9]. Skull metastases
from HCC predominantly affect males in their sixth and
seventh decades, with similar age and sex distributions to
those with only HCC [9].
Magnetic resonance imaging (MRI) of the skull metastasis from hepatocelluar carcinoma Figure 1
Magnetic resonance imaging (MRI) of the skull metastasis from hepatocelluar carcinoma. A) T1-weighted MRI 
and B) T2-weighted MRI demonstrating a homogeneous, well-defined, and iso-signal intensity mass in the occipital midline. C) 
Gadolinium enhanced T1-weighted MRI images showing a strong enhancement of the tumor.World Journal of Surgical Oncology 2008, 6:66 http://www.wjso.com/content/6/1/66
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In spite of the low incidence of skull metastases, there
have been interesting trends in the reports about skull
metastases from HCC. Moreover, in comparison with the
incidence of skull metastases before the 1980's, the inci-
dence after the 1990's has clearly increased because of a
prolonged survival rate due to recent progress in the diag-
nosis and treatment of HCC [4,7]. Therefore, particularly
in Asia, patients with HCC should be closely monitored
for skull metastases. Plain skull x-ray is the most frequent
initial diagnostic step in the patient with clinical suspi-
cion of a bone lesion and bone scan with technetium-
99m-methylene diphosphonate is widely used as a screen-
ing tool to detect bone metastases. On radiological exam-
ination, osteolytic-type behavior with a tendency to be
highly enhanced is the most common finding [6,7]. How-
ever these findings are not specific to just HCC: most skull
metastases appear as osteolytic, expansile, and hypervas-
cular lesions [10]. Metastases are the most common cra-
nial neoplasms in adults, of which 60% are from breast
and lung carcinoma, although hematogenous skull
metastases can be caused by nearly all types of tumors
[11].
Because of the wide spectrum of primary cancers causing
skull metastases, and because of their indistinguishable
radiological findings, pathological confirmation by
biopsy is required. Our case also required a biopsy for his-
topathological confirmation of the skull tumor. Metas-
tases from HCC seldom emerge as a first diagnosis of a
solitary skull tumor, because skull metastasis from HCC
prior to diagnosis of the primary cancer is very rare [7].
Moreover, our patient had a normal liver function test and
a normal alpha-fetoprotein and was asymptomatic from
his primary liver cancer. A solitary skull metastasis from
HCC is very rare, but this type of metastases could be
explained by the osseous route of HCC metastasis.
Metastases in the central nervous system from HCC gener-
ally occur through two different kinds of pathways in the
advanced stage of HCC [6,7]. One of them is the hematog-
enous route via the lung to the brain parenchyma without
skull involvement. In this group, the character of HCC is
defined as a "neutrophilic" cancer, and the lung is the
most common site of extracranial metastases. On the
other hand, the second route is the osseous route via
Batson's venous plexus to the skull. In this group, bone is
the most common site of extracranial metastases, and
HCC is characterized as an "osteophilic" cancer. Cancer
cells might disseminate within the dipole via the diploic
venous channels and expand through the inner and outer
table of the skull [7]. Therefore, it is difficult to find the
skull metastasis from HCC without the presence of other
bone metastases.
This patient initially visited the hospital due to the inci-
dentally discovered scalp mass. In the literature, a subcu-
taneous mass with occasional pain is the most common
clinical presentation (63%), followed by neurological def-
icits (44%), headache (11%), and seizure [1]. The neuro-
logical deficits, such as facial palsy, deafness, visual
disturbance, facial numbness, weakness of limbs, and
other cranial nerve palsies, are associated with the tumor
size and location. Neurological deficits are more fre-
quently present in metastases of the skull base rather than
the cranial vault [1,10].
Several treatment options can be used to treat the skull
metastases from HCC, including direct ethanol injection
therapy, radiotherapy, surgical resection, and supportive
management. Many previous reports suggest that most
patients with skull metastases died due to liver failure and
Abdominal computed tomography (CT) revealing two sepa- rate, low-density, 2-cm masses on segment II (A) and IV (B)  of the liver Figure 3
Abdominal computed tomography (CT) revealing two sepa-
rate, low-density, 2-cm masses on segment II (A) and IV (B) 
of the liver.
Hematoxylin-eosin staining (400× magnification) showing a  pleomorphic tumor cell with eosinophilic cytoplasm and  prominent nucleoli arranged in both a trabecular and solid  pattern, which is consistent with metastasis of HCC Figure 2
Hematoxylin-eosin staining (400× magnification) showing a 
pleomorphic tumor cell with eosinophilic cytoplasm and 
prominent nucleoli arranged in both a trabecular and solid 
pattern, which is consistent with metastasis of HCC.Publish with BioMed Central    and   every 
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that surgical resection of the metastatic lesion could not
prolong survival [1,4,10]. The stage of the primary cancer
is mostly associated with the prognosis. However, surgical
resection of the skull metastases is acceptable for prevent-
ing intracranial hemorrhage and neurological deteriora-
tion. Surgical intervention also allows for biopsy, whereby
the tumor can be histologically confirmed; such biopsies
are easier to perform in cranial vault-sited cases [1,3,12].
Conclusion
Although a solitary skull metastasis prior to the diagnosis
of HCC demonstrates rare metastatic behavior for HCC,
especially in Asia, skull metastases from HCC should be
included in the differential diagnosis of skull tumors,
even if the patient is asymptomatic of liver cirrhosis. With
the increase of survival in HCC patients, clinically signifi-
cant bone metastases have also increased, affecting the
patients' quality of life. Therefore, early diagnosis and
proper management of bone metastasis from HCC is
essential to prevent deterioration in the quality of life of
HCC patients.
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